Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The Lancet has published the results of the Procedural Pain in Premature Infants (Poppi) study, which was run by the Paediatric Neuroimaging Group and co-ordinated by the National Perinatal Epidemiology Unit (Clinical Trials Unit).

A The year-long study examined the effects of morphine as an analgesic for premature non-ventilated babies undergoing routine eye examinations. Thirty-one infants were enrolled in the trial, and assigned to either morphine or placebo treatment.

The results show that administration of oral morphine to non-ventilated premature infants prior to retinopathy of prematurity screening has the potential for harm without suggestion of analgesic efficacy. Difficulties in measuring infant pain are widely recognised, and the methodology used to measure both analgesic efficacy and side effects of a pharmacological intervention in the Poppi trial sets new standards for the conduct of clinical trials of analgesics in infants.

Completing the Poppi trial has been a fantastic achievement. The project has bought together people from many disciplines who want to improve the treatment of pain in prematurely-born infants. We are very excited about the next phase of our work where we will use the methodology developed in the Poppi trial to test the analgesic efficacy and safety of other pharmacological interventions.

 

 - said Professor Rebeccah Slater, head of Paediatric Neuroimaging.

 

 

 

 

 

 

 

 

 

For an overview of the procedure and results of the study, watch our animation:

 

The journal article can be found here: Analgesic efficacy and safety of morphine in the Procedural Pain in Premature Infants (Poppi) study: randomised placebo-controlled trial

Similar stories

The development of pain perception in early life

In this interview, Ebony chats with Rebeccah Slater, a professor of Pediatric Neuroimaging in the Department of Pediatrics (Oxford University, UK), about her research on neonatal pain perception and her involvement in FENS 2022. Slater’s lab focuses on how pain perception develops in early life and how this research can better equip doctors to manage and treat pain in babies.

Doctors learned how to save premature infants’ lives. They forgot about pain.

Scientists are investigating how to treat pain in babies who can’t tell you when it hurts.

Why it's so hard to treat pain in infants

For decades physicians believed that premature babies didn’t experience pain. Here’s what doctors know now – and the innovative solutions being embraced by today's caregivers.

Children’s pain ‘swept under the carpet for too long’ – Lancet Commission

The launch of Lancet Child and Adolescent Health Commission - the first ever to address paediatric pain - aims to raise the profile of children’s pain from early years to early adulthood.

New design of ‘bike helmet’ style brain scanner used with children for first time

A new wearable ‘bike helmet’ style brain scanner, that allows natural movement during scanning, has been used in a study with young children for the first time. This marks an important step towards improving our understanding of brain development in childhood.

Neuroimaging research featured in Blueprint Magazine

In the latest issue of the Blueprint, Shaunna Latchman meets Professor of Paediatric Neuroimaging, Rebeccah Slater to discuss the Paediatric Neuroimaging Group and find out why a gentle touch really does goes a long way.